down arrow

Fischer Medical

  • Market Cap: Mid Cap
  • Industry: Chemicals
  • ISIN: INE771F01025
  • NSEID:
  • BSEID: 524743
INR
834.80
14.8 (1.8%)
BSENSE

Apr 11, 12:51 PM

BSE+NSE Vol: 1.62 lacs

Click here to access the older version
  • Price Points
  • Score
  • Mojo Parameters
  • Total Return
  • News and Corporate Actions
  • Key factors
  • Shareholding
  • Financials
  • CompanyCV
stock-summaryCompany CV
About Fischer Medical Ventures Ltd stock-summary
stock-summary
Fischer Medical Ventures Ltd
Mid Cap
Chemicals
Fischer Chemic Ltd. was incorporated as a Public Limited Company and obtained Certificate of Commencement of Business. The Company formed an agreement with the Partnership firm M/s. Fischer Inorganics & Aromatics, Chennai to take over the partnership business as a going concern dated 19th January 1994. The partnership firm was engaged in the processing/Manufacturing of Laboratory Grade Chemicals.
Company Coordinates stock-summary
Company Details
104 1st Fl Bhhind Poisar Depot, Raghuleela Mall Kandivali (W) Mumbai Maharashtra : 400067
stock-summary
Tel:
stock-summary
http://www.fischerchemic.in
stock-summary
fischerchemicltd@gmail.com
Registrar Details
Adroit Corporate Services Pvt Ltd, 17-20 Jaferbhoy Industrial Estate , 1st Floor, Makwana Road, Marol Naka, Mumbai
stock-summary Capital Structure
Capital Structure stock-summary
Present Equity Capital
INR 53.50 Cr
Number of Shares
5.35 Cr
Face Value
INR 10.0
Date
Number
of Shares(Cr)
Equity
Capital (Rs Cr)
Shares Added
Face Value (Rs)
Reason
25-Jan-2024
5.35
53.50
51000000
10
Preferential basis
29-Jun-2023
25
2.50
2328000
10
Preferential basis
27-Nov-2017
1.72
0.17
-3268000
10
Capital Reduction & Conversion of Warrants
stock-recommendation Shareholding
Shareholding Snapshotstock-summary
Shareholding Compare (%holding) stock-summary
Majority shareholders

Promoters

Pledged Promoter Holdings

None

Mutual Funds

Held by 0 Schemes

FIIs

Held by 3 FIIs (5.06%)

Promoter with highest holding

Time Medical International Ventures Pte (52.0%)

Highest Public shareholder

Roopal Hitesh Kawa (0%)

Individual Investors Holdings

25.3%

stock-summary Board of Directors
stock-summary
stock-summary
Management
Designation
Remuneration
Sejal Soni
Non Executive Director
0
Ashishkumar Dhakan
Independent Non Exe. Director
0
Krishna Kumar Omprakash Dubey
Independent Director
0
Jeena Dineshchandra Suthar
Independent Women Director
0
Dilip Suryakant Jha
Director & CFO
0
stock-recommendationRaw Materials
Raw Materials Dashboard stock-summary
Raw Materials
Amount(Rs Cr)
% of RM Cost
 
Icon
No Data Available
stock-recommendation Finished Goods
Finished Goods Dashboard stock-summary
Finished Goods
Amount(Rs Cr)
% of Sales Turnover
Laboratory Chemicals
0.02
100.00%
 
100
Laboratory Chemicals
stock-recommendation Stock DNA
Revenue and Profits:
Net Sales:
12 Cr
(Quarterly Results - Dec 2024)
Net Profit:
0 Cr
stock-summary
Industry

Chemicals

stock-summary
Market cap

INR 5,225 Cr (Mid Cap)

stock-summary
P/E

2,843.00

stock-summary
Industry P/E

41

stock-summary
Dividend Yield

0.00%

stock-summary
Debt Equity

-0.05

stock-summary
Return on Equity

2.28%

stock-summary
Price to Book

64.93

Stock List
ABCDEFGHIJKLMNOPQRSTUVWXYZOther
Footer Logo
InfinHub Market Technologies FZ-LLC, Building-2, Unit 112, Dubai Internet City, Dubai, United Arab Emirates
GET THE MARKETSMOJO APP
Company
Stocks
Portfolio
Market
Webinars
"Investment in securities markets are subject to market risk. Read all the related documents carefully before investing."